Diginex Bolsters ESG RegTech with Acquisition of The Remedy Project

Event summary

  • Diginex Limited (DGNX) completed its acquisition of The Remedy Project, a Hong Kong-based advisory firm specializing in labor and human rights supply chain due diligence.
  • The consideration for the acquisition includes 1 million Diginex shares, with a potential for an additional 1 million shares based on performance targets over three years.
  • The Remedy Project was founded in 2020 and focuses on rights-holder-centered approaches to labor and human rights.
  • Diginex's existing platforms, diginexLUMEN and diginexAPPRISE, will be integrated with The Remedy Project's advisory services.

The big picture

The acquisition reflects the growing pressure on businesses to address human rights risks within their supply chains, fueled by regulatory changes and heightened stakeholder scrutiny. Diginex is positioning itself to be a key player in the emerging market for ESG RegTech, combining technology with specialized advisory services. The deal, valued at approximately $15 million based on current share prices, signals a willingness among RegTech providers to acquire specialized expertise to meet evolving client needs.

What we're watching

Regulatory Headwinds
The acquisition's success hinges on Diginex's ability to navigate and capitalize on increasingly stringent regulations like the EU Corporate Sustainability Due Diligence Directive, which will likely drive demand for these services.
Execution Risk
The earnout structure tied to operational and performance targets introduces execution risk; Diginex must effectively integrate The Remedy Project's expertise and achieve those targets to unlock the full value of the deal.
Market Adoption
The pace at which companies adopt comprehensive human rights due diligence solutions, particularly in Asia where The Remedy Project has deep expertise, will determine the long-term revenue potential for Diginex.

Related topics

ESG